Latest News for: kbp
Edit
Treatment-resistant Hypertension Market Growth Projections 2024-2034: DelveInsight Analysis | Idorsia Pharma, Ionis Pharma, KBP Biosciences, ...
GetNews 02 Apr 2025
Several prominent companies in the Treatment-Resistant Hypertension market, including Ionis Pharmaceutical's IONIS-AGT-LRx, KBP Biosciences' ocedurenone (KBP-5074), and others, are anticipated to influence the market dynamics from 2024 to 2034.
- 1